10th January 2020
USADA announced today that Ted Dreaver, of Ocala, Fla., an athlete in the sport of weightlifting, has accepted a 39-month suspension for an anti-doping rule violation.
Dreaver, 44, tested positive for an exogenous anabolic agent as the result of an in-competition drug test conducted at the National Masters Championships on March 30, 2019.
His urine samples were analyzed using a specialized test that differentiates between anabolic-androgenic steroids (AAS) naturally produced by the body and prohibited anabolic agents of external origin. Anabolic agents have powerful performance-enhancing capabilities and can give an athlete an unfair advantage over fellow competitors.
All AAS, including testosterone, are non-Specified Substances in the class of Anabolic Agents and are prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic Committee National Anti-Doping Policies, and the International Weightlifting Federation Anti-Doping Policy, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency (WADA) Prohibited List.
Dreaver received a nine-month reduction to the otherwise applicable period of ineligibility at the discretion of USADA and WADA, and in accordance with the rules, based on Dreaver’s prompt admission of the violation.
Dreaver’s 39-month period of ineligibility began on June 3, 2019, the date his provisional suspension was imposed. In addition, Dreaver has been disqualified from competitive results obtained on and subsequent to February 2, 2017, the date on which he first began testosterone therapy treatment, including forfeiture of any medals, points and prizes.